FDA+ channel feed

Short-term gov­ern­ment spend­ing bill in­cludes reau­tho­riza­tions of or­phan drug cred­its and oth­er phar­ma perks

3 years ago
Law

Roche wins ear­li­er-than-ex­pect­ed ap­proval for block­buster Tecen­triq in rare soft tis­sue can­cer

3 years ago
Pharma

Up­dat­ed: FDA ap­proves Mi­rati's KRAS drug in non-small cell lung can­cer

3 years ago
R&D
Pharma

Val­isure in the hot seat: New Form 483 over a 2021 in­spec­tion as CEO fires back

3 years ago
Pharma
Manufacturing

FDA re­view­ers head back to White Oak in 2023, with lead­er­ship look­ing to ap­pease a new Con­gress

3 years ago

Ahead of ad­comm, FDA rais­es un­cer­tain­ties on ben­e­fit-risk pro­file of Cy­to­ki­net­ic­s' po­ten­tial heart drug

3 years ago

Bags of shred­ded docs: In­di­an drug­mak­er Lupin hand­ed a Form 483 by FDA in­spec­tors

3 years ago
Pharma
Manufacturing

Bro­ken promis­es? FDA needs more pow­er to re­move drugs from mar­ket­place, JA­MA analy­sis finds

3 years ago

Scoop: On­copep­tides CEO ‘lean­ing to­ward’ giv­ing in to FDA with­draw­al re­quest amid ‘piss­ing con­test’ with reg­u­la­tors

3 years ago

FDA com­mis­sion­er on drug ap­provals: The prob­lem is­n't in­no­va­tion or speed

3 years ago

FDA au­tho­rizes bi­va­lent Covid boost­ers for chil­dren 6 months and up

3 years ago
Pharma
Coronavirus

QC vi­o­la­tions raised by FDA at an­oth­er Au­robindo site

3 years ago
Pharma
Manufacturing

FDA halts im­ports of sev­er­al Sun Phar­ma drugs made in In­dia due to out­stand­ing qual­i­ty is­sues

3 years ago
Pharma
Manufacturing

FDA pulls On­copep­tides' Pepax­to in­di­ca­tion, open­ing the door for dan­gling ac­cel­er­at­ed ap­proval en­force­ment

3 years ago

Glen­mark hit with warn­ing let­ter over pro­ce­dures, qual­i­ty con­trol is­sues at In­dia man­u­fac­tur­ing plant

3 years ago
Pharma
Manufacturing

FDA grants or­phan drug des­ig­na­tion to Al­ger­non's ifen­prodil, while ex­clu­siv­i­ty re­mains un­clear

3 years ago
Pharma

No­var­tis bol­sters Plu­vic­to's case in prostate can­cer with PhI­II re­sults

3 years ago
Pharma

Verve re­veals let­ter from FDA that lays out con­di­tions to lift base edit­ing tri­al hold

3 years ago
R&D

FDA's drug short­ages leader wants com­pa­nies to start re­port­ing in­creas­es in de­mand

3 years ago
Pharma
Manufacturing

Beam's base-edit­ed al­lo­gene­ic CAR-T gets FDA go-ahead af­ter four-month wait

3 years ago
Cell/Gene Tx

FDA re­jects Y-mAbs’ neu­rob­las­toma drug af­ter tak­ing is­sue with clin­i­cal tri­al de­sign

3 years ago
R&D

Rigel Phar­ma scores FDA ap­proval for leukemia, kick­ing off show­down with Servi­er in IDH1

3 years ago

Up­dat­ed: FDA re­mains silent on or­phan drug ex­clu­siv­i­ty af­ter last year's court loss

3 years ago

FDA ap­proves Re­by­ota, Fer­ring's poop-based drug to fight C. diff in­fec­tion

3 years ago
First page Previous page 66676869707172 Next page Last page
A service from the Financial Times